Finance

Lists
GUTS:NASDAQ
Fractyl Health Inc
$0.64
-0.48%
(-0.0031) 1D
$0.64
0.00% (0.00)
After hours
Closed: Sep 11, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for GUTS...
Open
$0.64
High
$0.66
Low
$0.63
Mkt. cap
102.37M
Avg. vol.
1.38M
Volume
751.82K
52-wk high
$2.44
52-wk low
$0.38
EPS
-$1.12
Shares outstanding
159.18M
No. of employees
100
Open
$0.64
High
$0.66
Low
$0.63
Mkt. cap
102.37M
Avg. vol.
1.38M
Volume
751.82K
52-wk high
$2.44
52-wk low
$0.38
EPS
-$1.12
Shares outstanding
159.18M
No. of employees
100
News stories
From web sources and news partners
Profile
Fractyl Health is a Burlington, Massachusetts-based healthcare company focused on metabolic diseases like obesity and type 2 diabetes. The company developed Revita, an outpatient endoscopic procedure to modify duodenal dysfunction, and Rejuva, a gene therapy platform in preclinical development to enable the pancreas to produce glucagon-like peptide-1. Wikipedia
About Fractyl Health Inc
CEO-
Employees100
Founded2010
HeadquartersBurlington, Massachusetts, United States
SectorMedical device
Analyst ratings
Based on 5 analysts giving stock ratings to GUTS in the past 3 months
Strong buy
Buy
4
Hold
1
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for GUTS in the last 3 months.
Highest
Current $0.64
$8.00 (+1,150.00%)
Average
$4.80 (+650.00%)
Lowest
$2.00 (+212.50%)
Analyst
Recommendation
Action
Price target
Projected
Date
Chase Knickerbocker
Craig-Hallum
Buy
Maintained
$4.00
+525%
09/02/2026
Joseph Pantginis
H.C. Wainwright
Buy
Maintained
$8.00
+1,150%
09/02/2026
Michael Ulz
Morgan Stanley
Hold
Maintained
$2.00
+212.5%
09/01/2026
Whitney Ijem
Canaccord Genuity
Buy
Maintained
$8.00
+1,150%
08/12/2026
Jason Gerberry
Bank of America Securities
Buy
Reiterated
$2.00
+212.5%
08/10/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
-
-
Operating expense
-
-
-
-
Total operating expenses
-
-
-
-
Operating income
-
-
-
-
Other non operating income
-
-
-
-
EBT including unusual items
-
-
-
-
EBT excluding unusual items
-
-
-
-
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-
-
-
-
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google apps